Octagon Capital Advisors LP Pmv Pharmaceuticals, Inc. Transaction History

Octagon Capital Advisors LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$3.94 - $6.27 $1.85 Million - $2.95 Million	470,000 New	470,000 $2.94 Million
Q4 2021 Feb 14, 2022	SELL	$19.99 - $30.24 $2 Million - $3.03 Million	-100,141 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$26.84 - $36.58 $4.02 Million - $5.48 Million	-149,859 Reduced 59.94%	100,141 $2.98 Million
Q4 2020 Feb 16, 2021	BUY	$31.86 - $61.51 $7.97 Million - $15.4 Million	250,000 New	250,000 $15.4 Million

41.9M

3.1K

1.7K

Ticker PMVP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,622,600
Market Cap $72.5M
Description
PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. The company's lead product candidate is PC14586, a small molecule that corrects a p53 protein containing the Y220C mutation and restores wild-type p53 function. It is also d...

Get notified when there are updates to the investment portfolio of Octagon Capital Advisors LP, based on Form 13F filings with the SEC.

Stay updated on Octagon Capital Advisors LP with notifications on news.